23
Oct
2024
On the 23rd of October, between 15:00-16:30 CEST, RWE4Decisions will be hosting its last webinar for 2024: “HTA/Payer National Collaborative Initiatives – The Role of Real-World Evidence”.
Join us to explore the creation and operation of the Joint Nordic HTA Bodies (JNHB) collaboration, how it evolved from FINOSE to JNHB, and how joint reports are taken up locally.
Make sure to sign up here!
PROGRAMME
15:00
Welcome from the co-moderators
-
Dr Tove Holm-LarsenChief Executive Officer, Silvi.ai / Professor, Ghent University
Dr Alexander NatzSecretary General, European Confederation of Pharmaceutical Entrepreneurs
15:05
Keynote presentations
Joint Nordic HTA Bodies (JNHB) – the Nordics example of collaboration
-
Dr Ehm Astrid Andersson GalijatovicMedical Assessor, Chief Consultant, Danish Medicines Council (DMC) -
Dr Maria ErikssonMedical Assessor, Dental and Pharmaceutical Benefits Agency (TLV)
15:25
Panel discussion
-
Prof Kimmo PorkkaProfessor of personalised cancer medicine / Chief physician, University of Helsinki -
Dr Christian DehlendorffBiostatistical Chief Consultant, Danish Medicines Council (DMC) -
Lars MøllerAccess & Value FIND Cluster Lead and Managing Director, Pfizer Denmark
16:00
Q&A with audience
16:25
Next steps
16:30
Meeting close
Upcoming Events
More
14
Nov
2024
RWE4Decisions Symposium: Developing Real-World Evidence to Deliver Innovation in HTA
09:00-13:00 CET
Hybrid, Brussels
